N@N

Alkermesa? Corporate Presentation to be Webcast at the 28th Annual JPMorgan Healthcare Conference

^{Published on 2010-01-06 20:40:20 - Market Wire}
 

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by JPMorgan on Wednesday, January 13, 2010 at 8:30 a.m. PT (11:30 a.m. ET) from the Westin St. Francis Hotel in San Francisco. The presentation may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL^® for alcohol dependence and manufactures RISPERDAL^® CONSTA^® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.